Schilling JM, Hughes CG, Wallace MS, et al. - Researchers conducted this survey to gain insight into participants’ attitudes and perspectives towards cannabis-based medicine with an emphasis on perception of “cannabidiol (CBD)” as well as its potential role for pain management. From seven pain management clinics in Southern California, 253 participants included. Of participants, 62.0% admitted using a CBD product [including products containing delta-9-tetrahydrocannabinol]. Most of the participants found these products helpful in relieving their pain (59.0%) and in enabling them to decrease their pain medications (67.6%), including opioids (53.7%). Participants believed CBD as a good treatment choice (71.1%), neither harmful (74.9%) and nor addictive (65.3%). Overall, the majority of the participants had a positive attitude regarding CBD products as a therapeutic choice, stated positive results when employed for multiple different conditions, and would like to collect information about and prescription for CBD from their physicians.